Overview of H. pylori infection and the mechanisms of action of amoxicillin and clarithromycin against H. pylori

Authors

  • Jiayu Liu

DOI:

https://doi.org/10.61173/aptsvq81

Keywords:

H. pylori, Amoxicillin, clarithromycin, anti-biotics

Abstract

H. pylori infection is a highly prevalent medical condition caused by Helicobacter pylori. Detailed recordation of this pathogen dates back to the 20th century. According to statistics, nearly half of the world’s population is infected with the bacterium so far, which indicates that the infection is a serious public health concern. H. pylori infection may lead to a spectrum of gastric disorders, such as chronic gastritis, gastroduodenal ulcer and gastric cancer. In addition, the infection can cause a series of extra gastric complications. As a bacterium that can survive under acidic conditions, H. pylori has a unique adaptation mechanism, and its virulence factors are also mentioned in this paper. Amoxicillin and clarithromycin are two frequently used antibiotics for the treatment of H.pylori infection. They are all produced by modifying original antibiotics and they have distinctive molecular structures. This paper introduces the mechanisms of action and targets of these two types of drugs. Common treatments for H.pylori infection and some special approaches for combating resistance to conventional antibiotics are also discussed in the text.

References

[1] Ayman Elbehiry, Eman Marzouk, Musaad Aldubaib, Adil [11] Christensen SB; Manuel Simões. Drugs That Changed Abalkhail, Sulaiman Anagreyyah, Nuha Anajirih, Abdulaziz Society: History and Current Status of the Early Antibiotics: M. Almuzaini, Mohammed Rawway, Abdulmajeed Alfadhel, Salvarsan, Sulfonamides, and β-Lactams; Published online 2021 Abdelmaged Draz, and Akram Abu-Okail; Marc Maresca, Oct 7. doi: 10.3390/molecules26196057 Academic Editor; Antibiotics (Basel). Helicobacter pylori [12] https://www.ncbi.nlm.nih.gov/books/NBK482250/ Infection: Current Status and Future Prospects on Diagnostic, [13] https://go.drugbank.com/drugs/DB01060 Therapeutic and Control Challenges; 2023 Feb; 12(2): 191. ; [14] W K Leung, D Y Graham; Clarithromycin for Helicobacter Published online 2023 Jan 17. doi: 10.3390/antibiotics1202019 pylori infection; doi: 10.1517/14656566.1.3.507.

[2] https://www.mayoclinic.org/diseases-conditions/h-pylori/ [15] https://go.drugbank.com/drugs/DB01211 diagnosis-treatment/drc-20356177# [16] Akiko Shiotani, Hong Lu, Maria Pina Dore, and David

[3] An Overview of Helicobacter pylori Infection; Rebecca Y. Graham; Treating Helicobacter pylori effectively while FitzGerald 1 , Sinéad M Smith 2 ; 2021:2283:1-14.;doi: minimizing misuse of antibiotics; Cleveland Clinic Journal 10.1007/978-1-0716-1302-3_1. of Medicine April 2017, 84 (4) 310-318; DOI: https://doi.

[4] https://www.mayoclinic.org/diseases-conditions/h-pylori/ org/10.3949/ccjm.84a.14110 symptoms-causes/syc-20356171 [17] Nasir Saleem and Colin W. Howden; Update on the

[5] https://my.clevelandclinic.org/health/diseases/24217- Management of Helicobacter pylori Infection; Published online atrophic-gastritis 2020 Jul 17. doi: 10.1007/s11938-020-00300-3

[6] Global burden of gastric cancer: epidemiological trends, risk

Downloads

Published

2025-07-06